Index of /wp-content/uploads/2021/03/

NameLast ModifiedSize
UpParent Directory
FileAvelumab-21001-Plain-English-Summary-21-12-21.pdf2023-03-09 11:31 340k
FileAvelumab-21001-Technical-Summary.pdf2023-03-09 11:31 516k
FileDRF-March-2021.doc2023-03-09 11:31 303k
FileEsketamine-Spravato-NCPE-Technical-Summary-Document-19055-updated-1.pdf2023-03-09 11:31 600k
FileEsketamine-Spravato-NCPE-Technical-Summary-Document-19055-updated.pdf2023-03-09 11:31 600k
FileEsketamine-Spravato-Plain-English-Summary-19055.pdf2023-03-09 11:31 340k
FileGuidelines-for-Patient-Organisations-v-1.2-final.docx2023-03-09 11:31 492k
FileNCPE-Webinar-Series-2021.pdf2023-03-09 11:31 383k
FilePGS-final-template-v2.4-final.docx2023-03-09 11:31 261k
FilePlain-English-Summary-gilteritinib_19043.pdf2023-03-09 11:31 200k
FilePlain-English-Summary-Pembro-21002.pdf2023-03-09 11:31 146k
FilePlain-English-Summary-risdiplam-21006-31.03.2022.pdf2023-03-09 11:31 327k
FilePlain-English-Summary-Trastuzumab-Emtansine-20002.pdf2023-03-09 11:31 202k
FilePlain-English-Summary_Cannabidiol-for-DS-HTA-ID-20004-Final.pdf2023-03-09 11:31 342k
FilePlain-English-Summary_Cannabidiol-for-LGS-HTA-ID-20005-Final-Report.pdf2023-03-09 11:31 202k
FileTechnical-Summary-Gilteritinib_19043.pdf2023-03-09 11:31 403k
FileTechnical-Summary-pembro-21002.pdf2023-03-09 11:31 500k
FileTechnical-summary-Risdiplam-HTAID-21006.pdf2023-03-09 11:31 743k
FileTechnical-Summary-Trastuzumab-Emtansine-20002.pdf2023-03-09 11:31 340k
FileTechnical-Summary_Cannabidiol-for-DS-HTA-ID-20004-Final-Report.pdf2023-03-09 11:31 325k
FileTechnical-Summary_Cannabidiol-for-LGS-HTA-ID-20005-Final-Report.pdf2023-03-09 11:31 587k
FileWebinar-II-slides-16th-March-2021.pdf2023-03-09 11:31 13529k
Proudly Served by LiteSpeed Web Server at www.ncpe.ie Port 443